← Back to Browse
ProductDiagnostic Tests

Neurodegenerative Disease Markers

United States

High-sensitivity assays for detection of neurological disease biomarkers including GFAP, NfL, APOE ε4, and pTau-217.

Manufactured by

United States

Beckman Coulter Diagnostics is a global leader in clinical laboratory diagnostics with over 90 years of experience in advancing diagnostic testing solutions. The company operates as a division of Danaher, a leading life sciences and diagnostics innovator. Beckman Coulter develops and manufactures diagnostic instruments and reagents used in hospitals, reference laboratories, research facilities, and physician offices worldwide. The company specializes in chemistry analyzers, immunoassay systems, hematology instruments, microbiology solutions, urinalysis platforms, and clinical information management systems. Key therapeutic areas include antimicrobial resistance management, host response to infection monitoring, cardiovascular disease diagnostics, diabetes management, neurodegenerative disease research, and sepsis detection. Beckman Coulter's products comply with the IVD Directive 98/79/EC and regulatory standards across major markets. The company emphasizes integrated workflow automation, digital laboratory solutions, and high-sensitivity diagnostic capabilities to improve clinical decision-making and patient outcomes globally.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

45
Relevant manufacturers
matched to this product
103
Relevant products analyzed
for supplier coverage
14
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

12 of 103 closest product alternatives

103 products

Aβ1-42,pTau-181,AD7C-NTP

Chongqing Kangjuquanhong Biotechnology Co.,Ltd. · China

Biomarker panel for Alzheimer's disease detection comprising amyloid-beta 1-42, phosphorylated tau-181, and AD7C-NTP. These in vitro diagnostic markers support early identification and assessment of neurodegenerative disease progression in clinical and research settings.

View Details

Metabolic Markers

Meridian Bioscience - Life Science Divis · United States

Antigens and antibodies for metabolic disorder detection including glucose and metabolic biomarkers. These reagents support development of diagnostic assays for metabolic disease screening.

View Details

Inflammation Markers

Hytest Ltd · Finland

Antibodies and antigens for inflammatory biomarker assays. Enables diagnostic testing for inflammatory conditions.

View Details

Kidney Disease Markers

Hytest Ltd · Finland

Immunological reagents for kidney disease assay development. Enables diagnostic testing for renal function and disease.

View Details

ELISA Immunoassay Reagents - Dementia Screening Series

SHENZHEN ANQUN BIOTECH CO.,LTD. · China

Proprietary ELISA reagents for early detection of neurodegenerative markers associated with Alzheimer's disease and age-related cognitive decline. This patented series represents the first domestically-developed solution for dementia biomarker detection.

View Details

GFAP Antibodies

BiosPacific · United States

Purified antibodies targeting glial fibrillary acidic protein for neurological diagnostics. Enables detection of astrocyte markers in brain injury and disease assessment.

View Details

Alzheimer's Disease (AD) Blood Biomarker Product

Shaoxing Shouren Medical Health & Technology Co., Ltd. · China

Blood biomarker test for Alzheimer's Disease detection and diagnosis. Utilizes advanced analytical methods to measure disease-specific protein markers in patient serum samples. Supports early disease identification and clinical assessment of neurodegenerative status.

View Details

Cognitive Disorder Early Detection Test

BioChain (Beijing) Science & Technology. Inc. · China

Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.

View Details

Neurodegeneration Diagnostic Tests

EUROIMMUN · United States

Diagnostic tests for detection of biomarkers associated with neurodegenerative diseases including Alzheimer's and Parkinson's disease. These tests support early identification and monitoring of neurological decline in patient populations.

View Details

Neuroscience Biomarker Antibodies

InVivo BioTech Services GmbH · Germany

A specialized collection of antibodies targeting key neuroscience biomarkers including Tau, Beta Amyloid, PrP, Alpha Synuclein, and TDP-43. These antibodies are designed for research, diagnostic, and preclinical use in neurodegenerative disease investigation.

View Details

Biomarker Analysis Platform

Brainsecrets.co.,Ltd · South Korea

System for identifying and analyzing neurobiological markers in EEG and physiological data for clinical diagnosis and treatment monitoring.

View Details

Brain Injury Marker Test (FIA)

Xiamen Biotime Biotechnology Co., Ltd. · China

Fluorescence immunoassay test for brain injury markers. Aids in diagnosis and assessment of traumatic brain injury and neurological damage.

View Details

91 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products